Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Elife ; 102021 04 13.
Artigo em Inglês | MEDLINE | ID: mdl-33847565

RESUMO

In Proteobacteria, integral outer membrane proteins (OMPs) are crucial for the maintenance of the envelope permeability barrier to some antibiotics and detergents. In Enterobacteria, envelope stress caused by unfolded OMPs activates the sigmaE (σE) transcriptional response. σE upregulates OMP biogenesis factors, including the ß-barrel assembly machinery (BAM) that catalyses OMP folding. Here we report that DolP (formerly YraP), a σE-upregulated and poorly understood outer membrane lipoprotein, is crucial for fitness in cells that undergo envelope stress. We demonstrate that DolP interacts with the BAM complex by associating with outer membrane-assembled BamA. We provide evidence that DolP is important for proper folding of BamA that overaccumulates in the outer membrane, thus supporting OMP biogenesis and envelope integrity. Notably, mid-cell recruitment of DolP had been linked to regulation of septal peptidoglycan remodelling by an unknown mechanism. We now reveal that, during envelope stress, DolP loses its association with the mid-cell, thereby suggesting a mechanistic link between envelope stress caused by impaired OMP biogenesis and the regulation of a late step of cell division.


Assuntos
Proteínas da Membrana Bacteriana Externa/genética , Membrana Externa Bacteriana/fisiologia , Proteínas de Escherichia coli/genética , Escherichia coli/genética , Lipoproteínas/genética , Proteínas da Membrana Bacteriana Externa/metabolismo , Escherichia coli/metabolismo , Proteínas de Escherichia coli/metabolismo , Aptidão Genética , Lipoproteínas/metabolismo , Dobramento de Proteína
2.
Cell Rep ; 30(9): 3092-3104.e4, 2020 03 03.
Artigo em Inglês | MEDLINE | ID: mdl-32130909

RESUMO

Mitochondrial preproteins contain amino-terminal presequences directing them to the presequence translocase of the mitochondrial inner membrane (TIM23 complex). Depending on additional downstream import signals, TIM23 either inserts preproteins into the inner membrane or translocates them into the matrix. Matrix import requires the coupling of the presequence translocase-associated motor (PAM) to TIM23. The molecular mechanisms coordinating preprotein recognition by TIM23 in the intermembrane space (IMS) with PAM activation in the matrix are unknown. Here we show that subsequent to presequence recognition in the IMS, the Tim50 matrix domain facilitates the recruitment of the coupling factor Pam17. Next, the IMS domain of Tim50 promotes PAM recruitment to TIM23. Finally, the Tim50 transmembrane segment stimulates the matrix-directed import-driving force exerted by PAM. We propose that recognition of preprotein segments in the IMS and transfer of signal information across the inner membrane by Tim50 determine import motor activation.


Assuntos
Membrana Celular/metabolismo , Mitocôndrias/metabolismo , Proteínas de Transporte da Membrana Mitocondrial/metabolismo , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/metabolismo , Proteínas de Transporte da Membrana Mitocondrial/química , Proteínas do Complexo de Importação de Proteína Precursora Mitocondrial , Modelos Biológicos , Proteínas Motores Moleculares/metabolismo , Domínios Proteicos , Transporte Proteico , Proteínas de Saccharomyces cerevisiae/química
3.
Biochim Biophys Acta Mol Cell Res ; 1866(5): 930-944, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30802482

RESUMO

Mitochondria are pivotal organelles for cellular signaling and metabolism, and their dysfunction leads to severe cellular stress. About 60-70% of the mitochondrial proteome consists of preproteins synthesized in the cytosol with an amino-terminal cleavable presequence targeting signal. The TIM23 complex transports presequence signals towards the mitochondrial matrix. Ultimately, the mature protein segments are either transported into the matrix or sorted to the inner membrane. To ensure accurate preprotein import into distinct mitochondrial sub-compartments, the TIM23 machinery adopts specific functional conformations and interacts with different partner complexes. Regulatory subunits modulate the translocase dynamics, tailoring the import reaction to the incoming preprotein. The mitochondrial membrane potential and the ATP generated via oxidative phosphorylation are key energy sources in driving the presequence import pathway. Thus, mitochondrial dysfunctions have rapid repercussions on biogenesis. Cellular mechanisms exploit the presequence import pathway to monitor mitochondrial dysfunctions and mount transcriptional and proteostatic responses to restore functionality.


Assuntos
Homeostase/fisiologia , Mitocôndrias/metabolismo , Membranas Mitocondriais/metabolismo , Biogênese de Organelas , Animais , Humanos , Proteínas de Membrana Transportadoras/genética , Proteínas de Membrana Transportadoras/metabolismo , Mitocôndrias/genética , Proteínas Mitocondriais/genética , Proteínas Mitocondriais/metabolismo , Transporte Proteico/fisiologia
4.
Eur J Heart Fail ; 14(8): 803-69, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22828712
5.
Neural Netw ; 19(2): 178-85, 2006 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-16616185

RESUMO

This paper presents a new development of the NeuroVaria method. NeuroVaria computes relevant atmospheric and oceanic parameters by minimizing the difference between the observed satellite reflectances and those computed from radiative transfer simulations modelled by artificial neural networks. Aerosol optical properties are computed using the Junge size distribution allowing taking into account highly absorbing aerosols. The major improvement to the method has been to implement an iterative cost function formulation that makes the minimization more efficient. This implementation of NeuroVaria has been applied to sea-viewing wide field-of-view sensor (SeaWiFS) imagery. A comparison with in situ measurements and the standard SeaWiFS results for cases without absorbing aerosols shows that this version of NeuroVaria remains consistent with the former. Finally, the processing of SeaWiFS images of a plume of absorbing aerosols off the US East coast demonstrate the ability of this improved version of NeuroVaria to deal with absorbing aerosols.


Assuntos
Aerossóis , Poluentes Atmosféricos/análise , Atmosfera/química , Simulação por Computador , Monitoramento Ambiental/métodos , Comunicações Via Satélite , Algoritmos , Cor , Oceanos e Mares , Radiação , Reprodutibilidade dos Testes , Fatores de Tempo
6.
Am J Hypertens ; 18(11): 1482-8, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-16280286

RESUMO

BACKGROUND: The objective of this prospective, randomized, open-label, blinded-endpoint study was to compare the antihypertensive efficacy of valsartan 80 mg v irbesartan 150 mg when combined with hydrochlorothiazide (HCTZ) 12.5 mg. METHODS: Untreated or uncontrolled hypertensive adults (n = 800) were enrolled by primary care physicians. After a 5-week open-label lead-in phase in which all patients received 12.5 mg HCTZ once daily, subjects whose blood pressure (BP) remained uncontrolled were randomized (n = 464) to valsartan/HCTZ (80/12.5 mg) or irbesartan/HCTZ (150/12.5 mg) for 8 weeks. Home BP monitoring (HBPM) was performed in the morning and in the evening for 5 days, at baseline, and after 8 weeks. Office BP measurements were obtained at baseline and after 8 weeks. RESULTS: Irbesartan/HCTZ produced greater reductions in average systolic BP (SBP) and diastolic BP (DBP) measured by HBPM than valsartan/HCTZ (SBP: -13.0 v -10.6 mm Hg, P = .0094; DBP: -9.5 v -7.4 mm Hg, P = .0007). These differences were more pronounced in the morning (trough) than in the evening. Office BP measurements also showed greater reductions in trough seated SBP and DBP with irbesartan/HCTZ compared with valsartan/HCTZ. Normalization rates observed with HBPM (SBP <135 mm Hg and DBP <85 mm Hg) were significantly greater with irbesartan/HCTZ than with valsartan/HCTZ (50.2 v 33.2%; P = .0003). The overall safety was similar in the two groups. CONCLUSIONS: The superior BP-lowering potency of the fixed combination irbesartan/HCTZ (150/12.5 mg) over valsartan/HCTZ (80/12.5 mg), evidenced independently from the investigators by HBPM, supports the use of this technique in trials with prospective, randomized, open-label, blinded-endpoint designs.


Assuntos
Bloqueadores do Receptor Tipo 1 de Angiotensina II/uso terapêutico , Anti-Hipertensivos/uso terapêutico , Pressão Sanguínea/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Idoso , Bloqueadores do Receptor Tipo 1 de Angiotensina II/efeitos adversos , Anti-Hipertensivos/efeitos adversos , Compostos de Bifenilo/efeitos adversos , Compostos de Bifenilo/uso terapêutico , Monitorização Ambulatorial da Pressão Arterial , Método Duplo-Cego , Quimioterapia Combinada , Feminino , Gastroenteropatias/induzido quimicamente , Humanos , Hidroclorotiazida/efeitos adversos , Hidroclorotiazida/uso terapêutico , Hipertensão/fisiopatologia , Irbesartana , Masculino , Pessoa de Meia-Idade , Doenças Musculoesqueléticas/induzido quimicamente , Estudos Prospectivos , Tetrazóis/efeitos adversos , Tetrazóis/uso terapêutico , Resultado do Tratamento , Valina/efeitos adversos , Valina/análogos & derivados , Valina/uso terapêutico , Valsartana
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...